VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EMN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EMNEastman Chemical Company
$66.92$7.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEMNFinancials

Eastman Chemical Company (EMN) Financials

30Y historyFree accessUpdated daily

Revenue growth has decelerated to a 4.9% contraction in 2026Q1, while gross margins have compressed significantly from 25.3% in 2024Q2 to 19.8% in the most recent quarter.

EMN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue8.64B8.75B9.38B9.2B10.54B10.48B8.46B9.25B10.12B9.51B8.95B9.56B9.51B9.36B8.06B7.18B5.8B5.02B6.73B6.83B7.45B7.06B6.58B5.8B5.32B5.39B5.29B4.59B4.48B4.68B4.78B
Revenue Growth %-7.72%-6.71%2%-12.69%0.5%23.85%-8.47%-8.64%6.39%6.36%-6.41%0.48%1.65%16.05%12.34%23.8%15.41%-25.3%-1.52%-8.32%5.54%7.28%13.45%9.02%-1.3%1.85%15.29%2.43%-4.21%-2.17%-5.12%
Cost of Goods Sold6.93B6.91B7.09B7.14B8.48B7.96B6.46B7B7.69B7.03B6.49B6.85B7.3B6.59B6.32B5.54B4.37B3.99B5.59B5.59B6.17B5.66B5.6B4.99B4.54B4.5B4.23B3.77B3.55B3.58B3.6B
COGS % of Revenue-78.93%75.59%77.58%80.48%75.98%76.31%75.69%76%73.9%72.55%71.68%76.73%70.4%78.35%77.15%75.35%79.38%83.13%81.83%82.86%80.11%85.14%86.03%85.36%83.43%79.86%82.09%79.13%76.57%75.34%
Gross Profit1.71B1.84B2.29B2.06B2.06B2.52B2B2.25B2.43B2.48B2.46B2.71B2.21B2.77B1.75B1.64B1.43B1.04B1.14B1.24B1.28B1.4B978M810M779M893M1.07B822M935M1.1B1.18B
Gross Margin %19.77%21.07%24.41%22.42%19.52%24.02%23.69%24.31%24%26.1%27.45%28.32%23.27%29.6%21.65%22.85%24.65%20.62%16.87%18.17%17.14%19.89%14.86%13.97%14.64%16.57%20.14%17.91%20.87%23.43%24.65%
Gross Profit Growth %--19.48%11.06%0.29%-18.35%25.59%-10.81%-7.45%-2.17%1.14%-9.31%22.32%-20.11%58.65%6.46%14.77%37.93%-8.72%-8.54%-2.82%-9.05%43.56%20.74%3.98%-12.77%-16.23%29.68%-12.09%-14.69%-7.04%-34.93%
Operating Expenses900M913M914M966M972M1.05B880M925M956M956M913M985M936M802M798M623M583M536M577M576M604M616M604M1.08B571M1.02B504M620M501M590M516M
OpEx % of Revenue-10.43%9.74%10.5%9.23%10.01%10.4%10%9.44%10.05%10.21%10.31%9.84%8.57%9.9%8.68%10.06%10.67%8.58%8.43%8.11%8.73%9.18%18.57%10.73%18.91%9.52%13.51%11.18%12.61%10.79%
Selling, General & Admin652M658M664M727M708M795M654M691M721M729M694M743M709M609M600M465M431M399M419M420M437M454M450M414M407M407M346M355M316M337M332M
SG&A % of Revenue-7.52%7.08%7.9%6.72%7.58%7.73%7.47%7.12%7.66%7.76%7.77%7.45%6.51%7.44%6.48%7.43%7.94%6.23%6.15%5.87%6.43%6.84%7.14%7.65%7.55%6.54%7.73%7.05%7.2%6.94%
Research & Development248M255M250M239M264M254M226M234M235M214M217M251M227M193M198M158M152M137M158M156M167M162M154M173M159M160M149M187M185M191M184M
R&D % of Revenue-2.91%2.66%2.6%2.51%2.42%2.67%2.53%2.32%2.25%2.43%2.63%2.39%2.06%2.46%2.2%2.62%2.73%2.35%2.28%2.24%2.29%2.34%2.98%2.99%2.97%2.82%4.07%4.13%4.08%3.85%
Other Operating Expenses00000000000000000000000490M5M452M9M78M062M0
Operating Income808M931M1.38B1.1B1.08B1.47B1.13B1.32B1.47B1.53B1.54B1.72B1.28B1.97B948M1.02B846M500M558M665M673M788M374M-267M208M-126M562M202M434M506M663M
Operating Margin %9.35%10.64%14.67%11.92%10.29%14.01%13.29%14.31%14.55%16.05%17.24%18.02%13.43%21.03%11.76%14.17%14.59%9.95%8.3%9.74%9.03%11.16%5.68%-4.6%3.91%-2.34%10.62%4.4%9.69%10.82%13.86%
Operating Income Growth %--32.34%25.55%1.11%-26.21%30.58%-14.97%-10.18%-3.54%-0.97%-10.45%34.85%-35.11%107.59%-6.78%20.21%69.2%-10.39%-16.09%-1.19%-14.59%110.7%240.07%-228.37%265.08%-122.42%178.22%-53.46%-14.23%-23.68%-31.22%
EBITDA1.2B1.44B1.89B1.59B1.56B2.01B1.7B1.93B2.07B2.11B2.12B2.29B1.73B2.4B1.31B1.29B1.13B774M825M992M981M1.09B696M100M605M309M980M585M785M833M977M
EBITDA Margin %13.83%16.5%20.09%17.33%14.82%19.15%20.07%20.9%20.49%22.19%23.72%23.99%18.16%25.66%16.22%17.97%19.42%15.41%12.27%14.52%13.17%15.47%10.58%1.72%11.37%5.73%18.52%12.75%17.52%17.81%20.43%
EBITDA Growth %-37.89%-23.4%18.26%2.11%-22.22%18.13%-12.11%-6.8%-1.75%-0.52%-7.46%32.77%-28.07%83.56%1.4%14.56%45.48%-6.18%-16.83%1.12%-10.16%56.9%596%-83.47%95.79%-68.47%67.52%-25.48%-5.76%-14.74%-23.19%
D&A (Non-Cash Add-back)387M513M509M498M477M538M574M610M601M584M580M571M450M433M360M273M280M274M267M327M308M304M322M367M397M435M418M383M351M327M314M
EBIT479M776M1.29B1.31B1.16B1.27B735M1.12B1.54B1.53B1.33B1.41B1.19B1.86B815M1.05B742M311M523M573M681M896M185M222M213M281M571M227M434M506M663M
Net Interest Income-159M-208M-200M-215M-182M-189M-201M-218M-235M-241M-255M-263M-187M-180M-143M-76M-99M-78M-70M000000000000
Interest Income5M016M10M6M3M4M3M3M3M3M3M16M6M5M7M6M00000000000000
Interest Expense216M208M216M225M188M192M205M221M238M244M258M266M203M186M148M83M105M78M70M000000000000
Other Income/Expense-357M-363M-298M-9M-107M-387M-595M-421M-163M-238M-493M-593M-287M-289M-299M-53M-210M-274M-129M-195M-97M-5M-310M-114M-124M-171M-110M-130M-74M-60M-56M
Pretax Income451M568M1.08B1.09B977M1.08B530M902M1.31B1.3B1.07B1.13B990M1.68B649M964M636M226M429M470M576M783M64M-381M84M-297M452M72M360M446M607M
Pretax Margin %5.22%6.49%11.49%11.82%9.27%10.32%6.26%9.75%12.94%13.69%11.96%11.81%10.41%17.94%8.05%13.43%10.97%4.5%6.38%6.88%7.73%11.09%0.97%-6.57%1.58%-5.51%8.54%1.57%8.03%9.53%12.69%
Income Tax52M93M170M191M181M215M41M140M226M-177M199M275M235M507M206M307M211M90M101M149M167M226M-106M-108M5M-118M149M24M111M160M227M
Effective Tax Rate %11.53%16.37%15.77%17.57%18.53%19.87%7.74%15.52%17.25%-13.59%18.6%24.36%23.74%30.2%31.74%31.85%33.18%39.82%23.54%31.7%28.99%28.86%-165.63%28.35%5.95%39.73%32.96%33.33%30.83%35.87%37.4%
Net Income399M474M905M894M793M857M478M759M1.08B1.47B866M848M751M1.17B437M696M438M136M346M300M409M557M170M-270M61M-179M303M48M249M286M380M
Net Margin %4.62%5.42%9.65%9.72%7.53%8.18%5.65%8.21%10.67%15.49%9.68%8.87%7.9%12.45%5.42%9.7%7.55%2.71%5.14%4.39%5.49%7.89%2.58%-4.66%1.15%-3.32%5.73%1.05%5.56%6.11%7.95%
Net Income Growth %-56.72%-47.62%1.23%12.74%-7.47%79.29%-37.02%-29.72%-26.73%70.21%2.12%12.92%-35.54%166.59%-37.21%58.9%222.06%-60.69%15.33%-26.65%-26.57%227.65%162.96%-542.62%134.08%-159.08%531.25%-80.72%-12.94%-24.74%-32.02%
Net Income (Continuing)399M475M908M896M796M867M489M762M1.08B1.39B859M854M755M1.17B443M657M425M136M328M321M427M557M170M-273M79M-175M303M48M249M286M380M
Discontinued Operations0000000000002M00013M00000000000000
Minority Interest77M76M73M72M83M84M85M74M75M77M76M80M80M79M85M0000000000000000
EPS (Diluted)-4.107.677.496.356.253.505.487.5610.095.845.664.977.442.934.862.960.932.281.792.463.411.09-1.750.40-1.171.970.311.571.822.40
EPS Growth %-55.98%-46.54%2.4%17.95%1.6%78.57%-36.13%-27.51%-25.07%72.77%3.18%13.88%-33.2%153.92%-39.71%64.19%218.28%-59.21%27.37%-27.24%-27.86%212.84%162.29%-537.5%134.19%-159.39%535.48%-80.25%-13.74%-24.17%-29.2%
EPS (Basic)-4.137.757.546.426.353.535.527.6510.185.885.715.037.573.004.983.040.942.301.822.493.451.10-1.750.40-1.171.980.311.581.832.42
Diluted Shares Outstanding0115.6M117.9M119.4M124.9M137.1M136.5M138.5M142.9M146.1M148.4M149.8M151.1M156.5M149.1M143.1M147.8M147.03M152M167.6M166.6M163.6M156.6M154.29M154.43M153.51M153.81M157.38M159.11M157.6M158.6M
Basic Shares Outstanding0114.7M116.7M118.6M123.5M134.9M135.5M137.4M141.2M144.8M147.3M148.6M149.5M154M145.5M139.7M144.2M144.68M150.4M165.29M164.26M161.4M155.2M154.29M154.43M153.51M153.42M157.38M158.1M156.2M157M
Dividend Payout Ratio-80.38%41.88%42.06%48.05%43.76%74.9%45.19%29.44%20.08%31.41%28.07%27.96%12.02%43.94%19.54%29%94.12%39.02%49%35.21%25.49%80.59%-221.31%-44.55%287.5%55.42%48.25%35.26%

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Cyclical volume and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Persistent Revenue Contraction Trends

According to recent financial disclosures, Eastman Chemical has experienced a sustained period of top-line pressure, with revenue growth declining by 4.9% in 2026Q1, reflecting broader challenges in volume leverage across its core specialty and intermediate segments compared to the prior year's performance.

The consistent negative growth trajectory suggests that the company is struggling to overcome destocking cycles in its key automotive and construction end-markets. Investors should monitor whether the recent startup of the Kingsport methanolysis facility can provide a sufficient volume offset to stabilize the top line in upcoming quarters.

Structural Margin Erosion Under Pressure

As reported in quarterly filings, Eastman's gross margin has compressed from a peak of 25.3% in 2024Q2 to 19.8% in 2026Q1, indicating that the company is facing significant difficulty in maintaining price-cost spreads amidst volatile raw material inputs and softening demand for specialty polymers.

The contraction in gross margins appears to reflect the company's high-fixed-cost manufacturing model, which struggles to absorb overhead when capacity utilization rates decline. This trend warrants further investigation into whether the current margin profile is a temporary cyclical trough or a more permanent shift in competitive pricing power.

Operating Leverage Efficiency Remains Constrained

Based on the provided income statement data, operating margins have retreated to 8.9% in 2026Q1 from a high of 16.8% in 2024Q4, suggesting that the company is currently unable to scale operating income effectively in the face of persistent revenue headwinds and elevated cost structures.

The inability to maintain operating leverage implies that SG&A and R&D expenses are not scaling down in proportion to the revenue decline, putting additional pressure on bottom-line profitability. Analysts should evaluate whether management can implement sufficient cost-discipline measures to protect operating margins if the current demand environment persists.

Earnings Volatility and Non-Operating Noise

Analysis of recent financial statements reveals significant volatility in net income, which dropped to $107 million in 2026Q1 from $330 million in 2024Q4, a trend exacerbated by non-operating items and the recent recognition of $49 million in stock-based compensation during the most recent quarter.

The sharp fluctuations in net income suggest that reported EPS may not fully reflect the underlying operational health of the business, as pension adjustments and maintenance turnaround timing often distort quarterly results. Investors should look past the headline EPS to assess the core cash-generating capability of the specialty materials portfolio.

Structural Risks to Circular Pivot

While management emphasizes the transition to circular economy products, the income statement data suggests that the company remains highly vulnerable to cyclical downturns, with the 2026Q1 performance highlighting a potential disconnect between long-term strategic investments and the immediate reality of declining core segment profitability.

Short-sellers may focus on the heavy capital intensity of the molecular recycling facilities, which could weigh on free cash flow if the expected price premiums for 'Tritan Renew' fail to materialize. The market may be underestimating the risk that legacy business segments continue to deteriorate faster than the new growth initiatives can scale.

EMN — Frequently Asked Questions

Quick answers to the most common questions about buying EMN stock.

What was Eastman Chemical Company's (EMN) revenue in 2025?

For fiscal year 2025, Eastman Chemical Company (EMN) reported total revenue of $8.75B. This represents a 83.0% increase compared to $4.78B in 1996.

Is Eastman Chemical Company (EMN) profitable?

Eastman Chemical Company (EMN) is profitable, generating $474.0M in net income for the fiscal year ending 2025 with a net profit margin of 5.4%.

What is Eastman Chemical Company's operating profit margin?

Eastman Chemical Company (EMN) reported an operating income of $931.0M, resulting in an operating profit margin of 10.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Eastman Chemical Company's gross profit and gross margin?

Eastman Chemical Company (EMN) generated $1.84B in gross profit for the year, representing a gross profit margin of 21.1%. This demonstrates the company's core pricing power and production efficiency.